Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cancer

Disease Area Cancer

DREAM Big

| James Costello

A collaborative challenge aims to address the problem of medication adherence by predicting adverse treatment events.

Disease Area Analytical science

In Spectroscopy and in Health

| Maria Montes-Bayón

We talk to Maria Montes-Bayón about mentors and the role of mass spectrometry in the field of human health.

Tools & Techniques Analytical science

Writing off Cancer

| Joanna Cummings

When it comes to identifying cancerous tissue, is the “MasSpec Pen” mightier than the sword?

Tools & Techniques Cancer

The Golden Touch

| James Strachan

Improving cancer drugs by “manufacturing” therapeutic compounds using gold nanoparticle catalysts.

Research Field Genetics

Kallikrein Dream

| Roisin McGuigan

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.

Research Field Cancer

Leidenfrost Nanochemistry

| James Strachan

Scientists fabricate anticancer nanoparticles by recreating deep sea volcano chemistry.

Tools & Techniques Cancer

Rush at Your Peril

| Eleftherios P. Diamandis

False discoveries have plagued biomarker research for years: don't trust everything you read.

Tools & Techniques Cancer

CEA: Overlooked and Underused

| Roisin McGuigan

Could an existing blood test improve treatment choices – and outcomes – for some colon cancer patients?

Tools & Techniques Cancer

Getting Smart with Clinical Trials

| Joy Yucaitis

Liquid biopsy technology could help boost clinical trial success.

Research Field Omics

Embracing the Proteogenomic Toolkit

| Andreas Hühmer

To win the war on cancer, we need to put proteomics on an equal footing with genomics.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register